Lean Big Data integration in systems biology and systems pharmacology

Avi Ma'ayan, Andrew D. Rouillard, Neil R. Clark, Zichen Wang, Qiaonan Duan, Yan Kou

Research output: Contribution to journalReview articlepeer-review

64 Scopus citations


Data sets from recent large-scale projects can be integrated into one unified puzzle that can provide new insights into how drugs and genetic perturbations applied to human cells are linked to whole-organism phenotypes. Data that report how drugs affect the phenotype of human cell lines and how drugs induce changes in gene and protein expression in human cell lines can be combined with knowledge about human disease, side effects induced by drugs, and mouse phenotypes. Such data integration efforts can be achieved through the conversion of data from the various resources into single-node-type networks, gene-set libraries, or multipartite graphs. This approach can lead us to the identification of more relationships between genes, drugs, and phenotypes as well as benchmark computational and experimental methods. Overall, this lean 'Big Data' integration strategy will bring us closer toward the goal of realizing personalized medicine.

Original languageEnglish
Pages (from-to)450-460
Number of pages11
JournalTrends in Pharmacological Sciences
Issue number9
StatePublished - 1 Sep 2014


  • data integration
  • network analysis
  • network pharmacology
  • side-effect prediction
  • systems pharmacology
  • target prediction


Dive into the research topics of 'Lean Big Data integration in systems biology and systems pharmacology'. Together they form a unique fingerprint.

Cite this